F-star Therapeutics, Inc.
FSTX · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $111,904 | $135,050 | $74,846 | $103,501 |
| - Cash | $35,568 | $52,963 | $68,801 | $78,549 |
| + Debt | $12,678 | $12,852 | $13,055 | $13,234 |
| Enterprise Value | $89,014 | $94,939 | $19,100 | $38,186 |
| Revenue | $1,125 | $0 | $2,551 | $17,499 |
| % Growth | – | -100% | -85.4% | – |
| Gross Profit | $1,125 | $0 | $2,551 | $17,499 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$17,780 | -$18,379 | -$11,534 | $3,572 |
| % Margin | -1,580.4% | – | -452.1% | 20.4% |
| Net Income | -$18,467 | -$19,121 | -$12,145 | $4,741 |
| % Margin | -1,641.5% | – | -476.1% | 27.1% |
| EPS Diluted | -0.84 | -0.89 | -0.58 | 0.23 |
| % Growth | 5.6% | -53.4% | -352.2% | – |
| Operating Cash Flow | -$16,548 | -$16,532 | -$11,615 | $6,781 |
| Capital Expenditures | -$37 | -$235 | $0 | $0 |
| Free Cash Flow | -$16,585 | -$16,767 | -$11,615 | $6,781 |